Table 1

Samples analysed during the study

Screening
S-FSHP-ASATP-Sodium
S-LHP-Calcium
S-SHBGfP-GlucoseFull blood cell count
S-TestosteroneP-GTB-HbA1c
S-TSHP-HDL Cholesterol
S-T4P-PotassiumU-screening for substance abuse*
P-AlbuminP-CholesterolU-Pregnancy test†
P-ALATP-Creatinine
P-ALPfP-LDL CholesterolResearch samples‡
At 4 weeks
P-ALATP-GTFull blood cell count
P-ALPP-Potassium
P-ASATP-CreatinineU-Pregnancy test†
P-GlucoseP-Sodium
At 8 weeks
P-ALATP-CreatinineU-Pregnancy test†
P-ALPP-SodiumP-Fluoxetine or U-Naltrexone§
P-ASATFull blood cell count
P-GTB-HbA1cResearch samples‡
P-Potassium
  • *Amphetamine, benzodiazepines, buprenorphine, cannabis, cocaine, fentanyl, methadone, oxycodone, tramadol and other opioids.

  • †Assigned female at birth only.

  • ‡ E.g. DNA extraction for genome-wide methylation analysis (EPIC) and second-generation DNA sequencing, oxytocin pretreatment and post-treatment.

  • §Depending on randomisation.